Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights


Emerging tools and needs for AAV vector characterisation

Fabien Dorange


Fabien Dorange holds a PhD in virology and worked as a postdoctoral researcher in the gene therapy field . Before joining Genethon, Fabien was Head of R&D viral safety in a CRO company (Texcell, France). He joined Genethon in 2016 and currently heads the analytical development department. He is responsible for developing analytical assays for characterization and release testing of gene therapy AAV vectors.

DOI: 10.18609/cgti.2019.161
Citation: Cell & Gene Therapy Insights 2019; 5(12), 1557–1560.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog